Funds · PLX

Who owns PLX?

Institutional ownership of Protalix BioTherapeutics Inc. (DE) from Form 13F, Q2 2026

102 institutional managers reported holding Protalix BioTherapeutics Inc. (DE) (PLX) in Form 13F filings for Q2 2026, with 14,461,410 shares worth $33.7M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters cut a net 2,400,522 shares (-14.4%). 19 opened new positions and 16 sold out.

Funds holding
102
Value held
$33.7M
New / sold out
19 / 16
Net shares, same filers
-14.4%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of PLX

FundValueShare of 13F holdingsSharesMove
BlackRock, Inc.$9.4M28.0%4,046,650Added
Renaissance Technologies LLC$2.6M7.6%1,096,000Trimmed
State Street Corp$2.3M6.8%983,582Added
Geode Capital Management, LLC$2.3M6.8%979,995Added
Northern Trust Corp$2.1M6.4%922,340Added
Vanguard Portfolio Management LLC$1.2M3.5%510,639Added
Stratos Wealth Partners, LTD.$1.2M3.5%500,000Unchanged
Dimensional Fund Advisors LP$1.1M3.4%493,424Added
Goldman Sachs Group Inc$1.1M3.3%475,922Added
Marshall Wace, LLP$1.1M3.1%452,757New
Citadel Advisors LLC$779K2.3%334,227New
STRS Ohio$690K2.0%296,100New
Bank of New York Mellon Corp$543K1.6%232,992Added
Main Street Financial Solutions, LLC$499K1.5%214,100First report
Bridgeway Capital Management, LLC$441K1.3%189,100Unchanged
Hillsdale Investment Management Inc.$433K1.3%185,711New
Charles Schwab Investment Management Inc$420K1.2%180,381Added
Millennium Management LLC$400K1.2%171,535New
AQR Capital Management LLC$391K1.2%167,826Added
Lazard Asset Management LLC$386K1.1%165,561Added
UBS Group AG$323K1.0%138,646Trimmed
JPMorgan Chase & Co$313K0.9%132,991Added
Nuveen, LLC$210K0.6%90,188Unchanged
Deutsche Bank Ag\$181K0.5%77,537Added
Vanguard Fiduciary Trust Co$164K0.5%70,277Added

Share of 13F holdings is each fund's shares as a share of the 14,461,410 PLX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $7.8M and sold $12.6M; 37 added and 17 trimmed.

Schedule 13D and 13G filings on PLX

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about PLX ownership

Who owns PLX stock?
102 institutional investment managers reported PLX positions in their Form 13F filings for Q2 2026, holding 14,461,410 shares worth $33.7M in total. BlackRock, Inc. reported the largest position.
Are funds buying or selling PLX?
In Q2 2026, 19 managers opened new PLX positions, 37 added, 17 trimmed and 16 sold out. Managers that filed in both quarters sold a net 2,400,522 shares.
How current is this PLX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PLX by CUSIP. Options are left out. PLX news and filings · PLX insider trades · Top funds